Supplements Studied for General Wellness

Each ingredient in this stack addresses a distinct physiological system, and the evidence supporting their inclusion draws on both mechanistic research and population-level dietary data.

Vitamin D3 operates as a secosteroid hormone precursor rather than a simple micronutrient. Once hydroxylated in the liver and kidneys to its active form (1,25-dihydroxyvitamin D), it binds to vitamin D receptors expressed across a wide range of tissues. In bone, it facilitates intestinal calcium absorption — without adequate vitamin D, the body absorbs only 10 to 15% of dietary calcium compared to 30 to 40% under sufficient conditions. Aranow (2011, Journal of Investigative Medicine) reviewed the immunological role of vitamin D and noted that the vitamin D receptor is expressed on B cells, T cells, and antigen-presenting cells, with deficiency associated with increased susceptibility to infection. SACN's 2016 report established the 10 microgram daily RNI to maintain serum 25(OH)D above the 25 nmol/L threshold linked to musculoskeletal risk. However, many researchers and clinicians consider 50 nmol/L a more appropriate target for broader health outcomes. A daily dose of 2,000 IU (50 micrograms) remains well within the NHS-stated upper limit of 4,000 IU and is a common choice for individuals seeking to reach and maintain sufficient serum levels, particularly between October and March.

Magnesium functions as a cofactor in over 300 enzymatic reactions, including those governing ATP production, DNA and RNA synthesis, and neuromuscular function. Its relevance to general wellness extends across energy metabolism, nervous system regulation, and blood pressure homeostasis. NDNS data consistently show that a meaningful proportion of the UK adult population fails to meet adequate intake levels from diet alone, with women aged 65 and over showing a gradual worsening trend over the survey period. The forms recommended here — glycinate and citrate — are organic magnesium salts with higher bioavailability and better gastrointestinal tolerability than magnesium oxide. EFSA set a supplemental tolerable upper intake level of 250mg from readily dissociable magnesium salts (separate from dietary intake) based on the threshold below which osmotic diarrhoea is unlikely, while the UK Expert Group on Vitamins and Minerals (EVM) set a higher guidance level of 400mg supplemental. A starting dose of 200 to 300mg supplemental elemental magnesium is prudent, increasing gradually if tolerated. Chelated forms such as glycinate and citrate tend to cause less gastrointestinal discomfort than magnesium oxide, partly because they are absorbed more efficiently and exert a weaker osmotic effect in the gut.

Omega-3 fatty acids — specifically EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) — serve as structural components of cell membranes and precursors to specialised pro-resolving mediators that modulate inflammatory responses. Khan et al. (2021, eClinicalMedicine) conducted a meta-analysis of 38 randomised controlled trials involving 149,051 participants and found that omega-3 supplementation was associated with reduced cardiovascular mortality, non-fatal myocardial infarction, and coronary heart disease events. DHA is concentrated in neural tissue and the retina, and observational research has linked higher circulating DHA levels with slower cognitive decline in older adults. UK dietary guidance recommends at least two portions of fish per week, including one of oily fish (approximately 450mg EPA and DHA combined), but NDNS data confirm that most adults fall short of this. A supplement providing 1,000 to 2,000mg combined EPA and DHA bridges this gap without exceeding the EFSA-assessed safe intake of up to 5g per day.

Vitamin K2 in the MK-7 (menaquinone-7) form completes the stack by addressing calcium trafficking. While vitamin D3 increases calcium absorption from the gut, K2 activates osteocalcin (which deposits calcium into bone matrix) and matrix Gla protein (which inhibits calcium accumulation in arterial walls). Van Ballegooijen et al. (2017, International Journal of Endocrinology) reviewed the synergistic interplay between vitamins D and K and concluded that combined supplementation appeared more effective than either nutrient alone for bone and cardiovascular health outcomes. Knapen et al. (2013, Osteoporosis International) demonstrated in a three-year randomised controlled trial of 244 postmenopausal women that 180 micrograms of MK-7 daily significantly decreased bone mineral density loss at the lumbar spine and femoral neck compared to placebo. A follow-up analysis from the same cohort (Knapen et al., 2015, Thrombosis and Haemostasis) found that the MK-7 group showed improved arterial elasticity while the placebo group experienced age-related arterial stiffening. At 100 micrograms daily, the dose in this stack sits below the studied therapeutic dose but above the estimated dietary intake for most UK adults, providing a proportionate baseline level.

A daily multivitamin represents the most common alternative to a targeted stack, offering broader coverage at the cost of lower individual doses. Most multivitamins contain vitamin D3 and magnesium, but typically at amounts below the levels included here — often 400 IU of D3 and 50 to 100mg of magnesium — and rarely include meaningful quantities of omega-3 or K2. A B-complex supplement may be worth considering alongside this stack for individuals with restricted diets, particularly vegans or those over 50, where vitamin B12 absorption can decline. Probiotics address an entirely different system — the gut microbiome — and while emerging research links gut health to immune function and mood, the evidence base remains less established than for the four nutrients included here. Vitamin C is well-studied for immune support, but dietary intake from fruit and vegetables in the UK generally meets requirements for most adults, making routine supplementation less critical than correcting the documented gaps this stack targets. The rationale for a focused four-ingredient approach is straightforward: it addresses the nutrients most consistently shown to be inadequate in UK dietary surveys, at doses supported by clinical research, without the diminishing returns that come from spreading a budget across dozens of ingredients at sub-therapeutic levels.